Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sarcoma Oncology Research Center, LLC
Stanford University
Pfizer
Memorial Sloan Kettering Cancer Center
Albert Einstein College of Medicine
Hoffmann-La Roche
Nektar Therapeutics
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
National Institutes of Health Clinical Center (CC)
Pfizer
Celgene
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
GE Healthcare
INSYS Therapeutics Inc